Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 17, Issue 19, pp. 6298-6303
PubMed
Published By
Print ISSN
Online ISSN
History
- Received June 9, 2011
- Revision received August 2, 2011
- Accepted August 11, 2011
- Published first August 19, 2011.
Article Versions
- Previous version (August 19, 2011 - 06:38).
- You are viewing the most recent version of this article.
Copyright & Usage
©2011 American Association for Cancer Research.
Author Information
- Jamie E. Chaft,
- Geoffrey R. Oxnard,
- Camelia S. Sima,
- Mark G. Kris,
- Vincent A. Miller, and
- Gregory J. Riely
- Authors' Affiliation: Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, New York
- Corresponding Author:
Gregory J. Riely, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10065. Phone: 212-639-3042; Fax: 212-794-4357; E-mail: rielyg{at}mskcc.org
October 2011
Volume 17, Issue 19
Volume 17, Issue 19
Disease Flare after Tyrosine Kinase Inhibitor Discontinuation in Patients with EGFR-Mutant Lung Cancer and Acquired Resistance to Erlotinib or Gefitinib: Implications for Clinical Trial Design
Jump to section
Advertisement